房间隔缺损和卵圆孔未闭封堵术的最新进展
Recent advances in closure of atrial septal defects and patent foramen ovale.
作者信息
Qureshi Athar M, Latson Larry A
机构信息
Center for Pediatric and Congenital Heart Disease The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 USA.
出版信息
F1000 Med Rep. 2010 Jan 27;2:8. doi: 10.3410/M2-8.
Abstract
Transcatheter closure of secundum atrial septal defect (ASD) and patent foramen ovale (PFO) is now widely accepted as an alternative to surgical closure. With currently available devices and techniques, approximately 80-90% of secundum ASDs and all PFOs can be closed percutaneously. While many devices are available, the use of any particular device is dictated largely by individual defect anatomy, device availability, long-term considerations, approval status (US Food and Drug Administration approval versus CE mark), and physician preference.
摘要
经导管闭合继发孔型房间隔缺损（ASD）和卵圆孔未闭（PFO）目前已被广泛接受为手术闭合的替代方法。使用现有的设备和技术，大约80%-90%的继发孔型ASD和所有PFO都可以通过经皮方式闭合。虽然有许多设备可供使用，但任何特定设备的使用很大程度上取决于个体缺损的解剖结构、设备的可获得性、长期考虑因素、批准状态（美国食品药品监督管理局批准与CE标志）以及医生的偏好。
相似文献
1
Recent advances in closure of atrial septal defects and patent foramen ovale.房间隔缺损和卵圆孔未闭封堵术的最新进展
F1000 Med Rep. 2010 Jan 27;2:8. doi: 10.3410/M2-8.
2
Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.大型队列中经导管房间隔缺损封堵术：中期随访结果
Congenit Heart Dis. 2013 Sep-Oct;8(5):418-27. doi: 10.1111/chd.12057. Epub 2013 Apr 22.
3
Role of intracardiac echocardiographic guidance in transcatheter closure of atrial septal defects and patent foramen ovale using the Amplatzer device.心腔内超声心动图引导在使用Amplatzer装置经导管封堵房间隔缺损和卵圆孔未闭中的作用。
J Interv Cardiol. 2003 Feb;16(1):51-62. doi: 10.1046/j.1540-8183.2003.08003.x.
4
Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.经导管闭合卵圆孔未闭、房间隔缺损和左心耳。
Minerva Cardioangiol. 2009 Feb;57(1):103-15.
5
Percutaneous Closure of a Cribriform Secundum Atrial Septal Defect and Patent Foramen Ovale.经皮闭合筛状继发孔房间隔缺损和卵圆孔未闭。
S D Med. 2021 May;74(5):227-229.
6
Feasibility of Device Closure for Multiple Atrial Septal Defects With an Inferior Sinus Venosus Defect: Procedural Planning Using Three-Dimensional Printed Models.应用三维打印模型对合并下腔静脉窦型房间隔缺损的多发房间隔缺损行介入封堵的可行性：操作规划。
Heart Lung Circ. 2020 Jun;29(6):914-920. doi: 10.1016/j.hlc.2019.07.004. Epub 2019 Jul 31.
7
Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale.房间隔缺损或卵圆孔未闭经导管封堵术后并发症的外科治疗
J Thorac Cardiovasc Surg. 2000 Dec;120(6):1034-9. doi: 10.1067/mtc.2000.111054.
8
Recent advances in managing septal defects: atrial septal defects.房间隔缺损治疗的最新进展
F1000Res. 2017 Nov 22;6:2042. doi: 10.12688/f1000research.11844.1. eCollection 2017.
9
10
Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.经导管房间隔缺损和卵圆孔未闭封堵器械治疗的近期和远期并发症：203 项研究 28142 例患者的荟萃分析。
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1123-38. doi: 10.1002/ccd.24875. Epub 2013 Aug 31.
引用本文的文献
1
Intracardiac echocardiography for percutaneous patent foramen ovale and atrial septal defect occlusion.经皮卵圆孔未闭和房间隔缺损封堵术的心脏内超声心动图检查
Herz. 2019 Aug;44(5):445-449. doi: 10.1007/s00059-017-4678-7. Epub 2018 Jan 26.
本文引用的文献
1
Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation.HELEX 器械部分脱出伴早期框架断裂和二尖瓣穿孔。
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):777-82. doi: 10.1002/ccd.22081.
2
Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations?Amplatzer 房间隔封堵器导致的侵蚀：经验丰富的操作者观点与制造商建议相悖？
Catheter Cardiovasc Interv. 2009 Jun 1;73(7):925-30. doi: 10.1002/ccd.21931.
3
Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.成人卵圆孔未闭和房间隔缺损的经皮封堵术：临床变量和医院手术量对住院期间不良事件的影响。
Am Heart J. 2009 May;157(5):867-74. doi: 10.1016/j.ahj.2009.02.019.
4
Fracture of the GORE HELEX septal occluder: associated factors and clinical outcomes.戈尔赫利克斯（GORE HELEX）房间隔封堵器骨折：相关因素及临床结局
Catheter Cardiovasc Interv. 2009 Jun 1;73(7):941-8. doi: 10.1002/ccd.21929.
5
Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients.继发孔型房间隔缺损的治疗：1013例连续患者年龄及缺损形态的影响
Am Heart J. 2008 Oct;156(4):706-12. doi: 10.1016/j.ahj.2008.06.008. Epub 2008 Jul 30.
6
Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.房间隔缺损和卵圆孔未闭经皮封堵术后主动脉瓣反流的发生率及预后
Heart. 2008 Jul;94(7):844-7. doi: 10.1136/hrt.2007.132662. Epub 2007 Dec 10.
7
Real-time tracking and shape analysis of atrial septal defects in 3D echocardiography.三维超声心动图中心房间隔缺损的实时跟踪与形态分析
Acad Radiol. 2007 Nov;14(11):1298-309. doi: 10.1016/j.acra.2007.07.011.
8
Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
Circulation. 2007 Oct 9;116(15):1701-6. doi: 10.1161/CIRCULATIONAHA.107.696310. Epub 2007 Sep 24.
9
Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.美国关于用于经皮闭合继发孔型房间隔缺损的HELEX房间隔封堵器的多中心关键研究结果。
J Am Coll Cardiol. 2007 Jun 5;49(22):2215-21. doi: 10.1016/j.jacc.2006.11.053. Epub 2007 May 9.
10
BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts.BioSTAR评估研究（BEST）：一项前瞻性、多中心的I期临床试验，旨在评估BioSTAR生物可吸收间隔修复植入物用于闭合心房水平分流的可行性、有效性和安全性。
Circulation. 2006 Oct 31;114(18):1962-7. doi: 10.1161/CIRCULATIONAHA.106.664672. Epub 2006 Oct 24.
Zotero 插件